From medical weight loss and semaglutide to IV infusions and aesthetic treatments, our Naperville clinic offers a full range of health and wellness services built around your goals.
MEDI0382, a GLP-1/glucagon receptor dual agonist, meets safety and tolerability endpoints in a single-dose, healthy-subject, randomized, phase 1 study
The month-to-month plan is available if you prefer flexibility from the start
Understanding long-term weight loss sustainability clarifies what these patterns mean
The SHP provides health care coverage to nearly 750,000 teachers, state employees, retirees, and their dependents
Developed by a team of top Equinox Coaches, this comprehensive guide covers weight loss on GLP-1 in detail, including topics like drug background, risk efficacy, relapse management, fat loss programming for exercise, and habit development